The UK Advanced Research and Invention Agency is adopting a funding strategy that emphasizes high risk and a tolerance for failure [1].
This shift represents a departure from traditional scientific funding models. By prioritizing high-turnover projects, the agency aims to accelerate breakthroughs that are often avoided by more conservative institutions due to the possibility of unsuccessful outcomes.
Kathleen Fisher, the head of ARIA, said the agency's approach is "high turnover, high risk and a licence to fail" [1]. This philosophy allows researchers to pursue ambitious goals without the immediate pressure of guaranteed success, treating failure as a necessary component of the discovery process.
Fisher said the agency operates under a 10-year tenure [1]. Now three years into that period, the organization is focusing on the ability to pivot quickly and discard unsuccessful paths in favor of more promising avenues [1].
The strategy is designed to foster an environment where revolutionary science can thrive. By accepting that many high-risk projects will not reach their intended goal, ARIA intends to identify the few transformative successes that can redefine entire fields of study [1].
This model contrasts with standard grant processes that often require extensive preliminary data to prove feasibility. Instead, ARIA is positioning itself as a vehicle for high-stakes experimentation within the UK scientific community [1].
“"high turnover, high risk and a licence to fail"”
The adoption of a 'licence to fail' model suggests a systemic shift in how the UK views the economics of innovation. By decoupling funding from the requirement of guaranteed success, ARIA is attempting to bridge the 'valley of death' between basic research and practical application, effectively treating scientific discovery more like venture capital than traditional academic patronage.
